Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

MARTIN-LESTER TRANSGROW W/TRIMETHOPRIN

K-Number: K760692 · 1976-10-07

ApplicantFlow Laboratories, Inc.
Decision Date1976-10-07
Product CodeJTY
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

MARTIN-LESTER TRANSGROW W/TRIMETHOPRIN is the device name listed in this FDA 510(k) record. The listed applicant is Flow Laboratories, Inc.. It received FDA 510(k) clearance on 1976-10-07 under 510(k) number K760692. The device is classified under product code JTY. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the MARTIN-LESTER TRANSGROW W/TRIMETHOPRIN?

MARTIN-LESTER TRANSGROW W/TRIMETHOPRIN is a medical device that received FDA 510(k) clearance on 1976-10-07. The listed applicant is Flow Laboratories, Inc.. The 510(k) number is K760692.

When did MARTIN-LESTER TRANSGROW W/TRIMETHOPRIN receive FDA 510(k) clearance?

MARTIN-LESTER TRANSGROW W/TRIMETHOPRIN received FDA 510(k) clearance on 1976-10-07, under 510(k) number K760692.

Who is the listed applicant for MARTIN-LESTER TRANSGROW W/TRIMETHOPRIN?

The FDA 510(k) record lists Flow Laboratories, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for MARTIN-LESTER TRANSGROW W/TRIMETHOPRIN?

The FDA product code for MARTIN-LESTER TRANSGROW W/TRIMETHOPRIN is JTY.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Flow Laboratories, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K861897UNISKAN IIK862066TITERTEK MICROPLATE WASHER S-12K861824GENTAMICIN SULFATE SOLUTION (10MG GENTAMICIN)K861823GENTAMICIN SULFATE SOLUTION (50MG GENTAMICIN)K861791PENICILLIN-STREPTOMYCIN-FUNGIZONEK860762GAMMA-FREE HORSE SERUM

View all 57 devices →

Related Devices (Code: JTY)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K210511InTray GCBiomed Diagnostics IncorporatedK993033INTRAY GCBiomed Diagnostics, Inc.K954986GC BASE W/ 1% GCHIRemel, L.P.K950196CULTURE MEDIA, FOR ISOLATION OF PATHOGENIC NEISSERIABioclinical Systems, Inc.K933122MICROBIOLOGICAL CULTURE MEDIA,MARTIN LEWIS AGARBioclinical Systems, Inc.K933121MICROBIOLOGICAL CULTURE MEDIA,CHOCOLATE AGARBioclinical Systems, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑